본문 바로가기
KERD
논문KCI 등재

Non-gastric Marginal Zone B-cell Lymphoma in Korea: Clinical Features, Treatment, and Prognostic Factors

서철원|오성용
대한내과학회 (The Korean Association Of Internal Medicine)|2010.09|The Korean Journal of Internal Medicine|제25권 제3호|pp. 227-236

2

조회

0

다운로드

5

인용

0

참고문헌

키워드

B-cellLymphomamarginal zone; Korea
주제분류내과학

초록

Marginal zone B-cell lymphoma (MZL) is the second most common subtype of non-Hodgkin’s lymphoma in Korea (17.3%). Mucosa-associated lymphoid tissue (MALT) can develop in almost any organ as a result of exposure to a persistent stimulus, such as chronic infection or certain autoimmune processes. Under conditions of prolonged lymphoid proliferation, a malignant clone may emerge, which is followed by the development of a MALT lymphoma. Whereas MALT lymphoma of the stomach is the most common and the most extensively studied, we focus on non-gastric MZL studies conducted in Korea that highlight the most recent advances with respect to MZL definition, etiology, clinical characteristics, natural history, treatment approaches, outcomes, and prognostic factors. Moreover, we discuss current organ-specific considerations and controversies, and identify areas for future research. (Korean J Intern Med 2010;25:227-236)

Abstract

Marginal zone B-cell lymphoma (MZL) is the second most common subtype of non-Hodgkin’s lymphoma in Korea (17.3%). Mucosa-associated lymphoid tissue (MALT) can develop in almost any organ as a result of exposure to a persistent stimulus, such as chronic infection or certain autoimmune processes. Under conditions of prolonged lymphoid proliferation, a malignant clone may emerge, which is followed by the development of a MALT lymphoma. Whereas MALT lymphoma of the stomach is the most common and the most extensively studied, we focus on non-gastric MZL studies conducted in Korea that highlight the most recent advances with respect to MZL definition, etiology, clinical characteristics, natural history, treatment approaches, outcomes, and prognostic factors. Moreover, we discuss current organ-specific considerations and controversies, and identify areas for future research. (Korean J Intern Med 2010;25:227-236)

참고문헌 (62)

  1. Swerdlow SH, "WHO Classification of Tumours of Pathology and Genetics of Tumours of Haematolopoietic and Lymphoid Tisses" (2008), IARC Press
  2. Zucca E, "Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue", Blood, 101, pp.2489~2495 (2003)
  3. Zinzani PL, "Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: analysis of 75 patients", J Clin Oncol, 17, pp.1254~ (1999)
  4. Thieblemont C, "Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed", Blood, 95, pp.802~806 (2000)
  5. Ko YH, "REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma", Cancer, 83, pp.806~812 (1998)
  6. 원영주, "Nationwide Cancer Incidence in Korea, 2003~2005", Cancer Research and Treatment, 41(3), pp.122~131 (2009), 대한암학회
  7. The Non-Hodgkin’s Lymphoma Classification Project, "A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin’s lymphoma", Blood, 89, pp.3909~3918 (1997)
  8. Wotherspoon AC, "Gastric MALT lymphoma and Helicobacter pylori", Yale J Biol Med, 69, pp.61~68 (1996)
  9. Roggero E, "Eradication of Borrelia burgdorferi infection in primary marginal zone B-cell lymphoma of the skin", Hum Pathol, 31, pp.263~268 (2000)
  10. Ferreri AJ, "Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas", J Natl Cancer Inst, 96, pp.586~594 (2004)
  11. Lecuit M, "Immunoproliferative small intestinal disease associated with Campylobacter jejuni", N Engl J Med, 350, pp.239~248 (2004)
  12. Hyjek E, "Primary B cell lymphoma of the thyroid and its relationship to Hashimoto’s thyroiditis", Hum Pathol, 19, pp.1315~1326 (1988)
  13. Isaacson PG, "Extranodal lymphomas: the MALT concept", Verh Dtsch Ges Pathol, 76, pp.14~23 (1992)
  14. Yoo C, "Chlamydia psittaci infection and clinicopathologic analysis of ocular adnexal lymphomas in Korea", Am J Hematol, 82, pp.821~823 (2007)
  15. Kim TM, "First-line therapy with doxycycline in ocular adnexal mucosa-associated lymphoid tissue lymphoma: a retrospective analysis of clinical predictors", Cancer Sci, 101, pp.1199~1203 (2010)
  16. Kim JH, "Clinical investigation of gastric MALT lymphoma", Korean J Med, 61, pp.417~423 (2001)
  17. Oh SY, "Extra-gastric MALT lymphoma: Analysis of 50 cases", Korean J Med, 59, pp.261~267 (2000)
  18. Oh SY, "Nongastric marginal zone B-cell lymphoma: analysis of 247 cases", Am J Hematol, 82, pp.446~452 (2007)
  19. Oh SY, "Nodal marginal zone B-cell lymphoma: analysis of 36 cases. Clinical presentation and treatment outcomes of nodal marginal zone B-cell lymphoma", Ann Hematol, 85, pp.781~786 (2006)
  20. Oh SY, "Relapsed or refractory nongastric marginal zone B-cell lymphoma: multicenter retrospective analysis of 92 cases", Am J Hematol, 84, pp.826~829 (2009)
  21. Kang HJ, "Rituximab plus CVP (cyclophosphamide, vincristine, and prednisolone) combination chemotherapy on advanced stage marginal zone B-cell lymphoma", Haematologica, 95(s2), pp.623~ (2010)
  22. Suh C, "Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue arising in the extracranial head and neck region: a high rate of dissemination and disease recurrence", Oral Oncol, 44, pp.949~955 (2008)
  23. Isaacson PG, "Update on MALT lymphomas", Best Pract Res Clin Haematol, 18, pp.57~68 (2005)
  24. Zucca E, "Marginal zone lymphomas", Hematol Oncol Clin North Am, 22, pp.883~901 (2008)
  25. Ferreri AJ, "Marginal-zone lymphoma", Crit Rev Oncol Hematol, 63, pp.245~256 (2007)
  26. Oh SY, "Phase II study of gemcitabine for treatment of patients with advanced stage marginal zone B-cell lymphoma: Consortium for Improving Survival of Lymphoma (CISL) trial", Invest New Drugs, 28, pp.171~177 (2010)
  27. "A predictive model for aggressive non-Hodgkin’s lymphoma. The International Non-Hodgkin’s Lymphoma Prognostic Factors Project", N Engl J Med, 329, pp.987~994 (1993)
  28. López-Guillermo A, "Applicability of the International Index for aggressive lymphomas to patients with low-grade lymphoma", J Clin Oncol, 12, pp.1343~1348 (1994)
  29. Foussard C, "Is the International Prognostic Index for aggressive lymphomas useful for low-grade lymphoma patients? Applicability to stage III-IV patients", Ann Oncol, 8, pp.49~52 (1997), The GOELAMS Group
  30. Solal-Céligny P, "Follicular lymphoma international prognostic index", Blood, 104, pp.1258~1265 (2004)
  31. Nathwani BN, "Marginal zone Bcell lymphoma: a clinical comparison of nodal and mucosaassociated lymphoid tissue types. Non-Hodgkin’s Lymphoma Classification Project", J Clin Oncol, 17, pp.2486~2492 (1999)
  32. Oh SY, "Nongastric marginal zone B-cell lymphoma: a prognostic model from a retrospective multicenter study", Cancer Lett, 258, pp.90~97 (2007)
  33. Oh DE, "Lymphoproliferative diseases of the ocular adnexa in Korea", Arch Ophthalmol, 125, pp.1668~1673 (2007)
  34. Cho EY, "Clinicopathologic analysis of ocular adnexal lymphomas: extranodal marginal zone b-cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects younger patients", Am J Hematol, 73, pp.87~96 (2003)
  35. Yoon JS, "Prognosis for patients in a Korean population with ocular adnexal lymphoproliferative lesions", Ophthal Plast Reconstr Surg, 23, pp.94~99 (2007)
  36. Lee JL, "Extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue-type of the orbit and ocular adnexa", Ann Hematol, 84, pp.13~18 (2005)
  37. Suh CO, "Orbital marginal zone B-cell lymphoma of MALT: radiotherapy results and clinical behavior", Int J Radiat Oncol Biol Phys, 65, pp.228~233 (2006)
  38. Nam H, "Prognostic significance of anatomic subsites: results of radiation therapy for 66 patients with localized orbital marginal zone B cell lymphoma", Radiother Oncol, 90, pp.236~241 (2009)
  39. Son SH, "Primary radiation therapy in patients with localized orbital marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT Lymphoma)", Int J Radiat Oncol Biol Phys, 77, pp.86~91 (2010)
  40. Song EK, "Efficacy of chemotherapy as a first-line treatment in ocular adnexal extranodal marginal zone Bcell lymphoma", Ann Oncol, 19, pp.242~246 (2008)
  41. Ferraro P, "Primary non-Hodgkin’s lymphoma of the lung", Ann Thorac Surg, 69, pp.993~997 (2000)
  42. Ahmed S, "Low-grade B-cell bronchial associated lymphoid tissue (BALT) lymphoma", Cancer Invest, 20, pp.1059~1068 (2002)
  43. Ahmed S, "Bronchial-associated lymphoid tissue lymphoma: a clinical study of a rare disease", Eur J Cancer, 40, pp.1320~1326 (2004)
  44. Zinzani PL, "Bronchus-associated lymphoid tissue lymphomas: an update of a rare extranodal maltoma", Clin Lymphoma Myeloma, 7, pp.566~572 (2007)
  45. Oh SY, "Pulmonary marginal zone B-cell lymphoma of MALT type--what is a prognostic factor and which is the optimal treatment, operation, or chemotherapy: Consortium for Improving Survival of Lymphoma (CISL) study", Ann Hematol, 89, pp.563~568 (2010)
  46. Bae YA, "Marginal zone B-cell lymphoma of bronchus-associated lymphoid tissue: imaging findings in 21 patients", Chest, 133, pp.433~440 (2008)
  47. Xu HY, "Diagnosis and treatment of pulmonary mucosa-associated lymphoid tissue lymphoma", Chin Med J (Engl), 120, pp.648~651 (2007)
  48. Kim JH, "Primary pulmonary non-Hodgkin’s lymphoma", Jpn J Clin Oncol, 34, pp.510~514 (2004)
  49. Stefanovic A, "Pulmonary marginal zone lymphoma: a single centre experience and review of the SEER database", Leuk Lymphoma, 49, pp.1311~1320 (2008)
  50. Koch P, "Primary gastrointestinal non-Hodgkin’s lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01", 92, 2001, pp.19, 3861~3873
  51. Kohno S, "Clinicopathological analysis of 143 primary malignant lymphomas in the small and large intestines based on the new WHO classification", Histopathology, 43, pp.135~143 (2003)
  52. Oh SY, "Intestinal marginal zone B-cell lymphoma of MALT type: clinical manifestation and outcome of a rare disease", Eur J Haematol, 79, pp.287~291 (2007)
  53. Conconi A, "Nodal marginal zone Bcell lymphomas may arise from different subsets of marginal zone B lymphocytes", Blood, 98, pp.781~786 (2001)
  54. Nathwani BN, "Nodal monocytoid B-cell lymphoma (nodal marginalzone B-cell lymphoma)", Semin Hematol, 36, pp.128~138 (1999)
  55. Troussard X, "Splenic lymphoma with villous lymphocytes: clinical presentation, biology and prognostic factors in a series of 100 patients. Groupe Francais d’Hématologie Cellulaire (GFHC)", Br J Haematol, 93, pp.731~736 (1996)
  56. Chacón JI, "Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients", Blood, 100, pp.1648~1654 (2002)
  57. Thieblemont C, "Splenic marginal-zone lymphoma: a distinct clinical and pathological entity", Lancet Oncol, 4, pp.95~103 (2003)
  58. Bertoni F, "State-of-the-art therapeutics: marginal-zone lymphoma", J Clin Oncol, 23, pp.6415~6420 (2005)
  59. Arcaini L, "Combination of rituximab, cyclophosphamide, and vincristine induces complete hematologic remission of splenic marginal zone lymphoma", Clin Lymphoma, 4, pp.250~252 (2004)
  60. Paydas S, "Successful rituximab therapy for hemolytic anemia associated with relapsed splenic marginal zone lymphoma with leukemic phase", Leuk Lymphoma, 44, pp.2165~2166 (2003)
  61. Hermine O, "Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection", N Engl J Med, 347, pp.89~94 (2002)
  62. Vallisa D, "Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin’s lymphoma: a multicenter Italian experience", J Clin Oncol, 23, pp.468~473 (2005)

관련 논문AI추천

WHO Classification of Malignant Lymphomas in Korea: Report of the Third Nationwide Study강윤경, 강창석, 고영혜, 고재향, 김민경, 김완섭, 김윤정, 김인선, 김진만, 김철우, 김현정, 김희경, 남종희, 문형배, 박찬금, 박태인, 오영하, 이동화, 이승숙, 이종실, 이주희, 이혜경, 임성철, 장규윤, 장희경, 전윤경, 정혜라, 조민선, 차희정, 최석진, 한재호, 허주령, 홍숙희대한병리학회 · Journal of Pathology and Translational Medicine2011 · 제45권 제3호Low-grade mucosa-associated lymphoid tissue(MALT) marginal zone B-cell lymphoma of the tongue-A case report권용대, 김여갑, 김영란, 오주영, 이백수, 최병준대한구강악안면외과학회 · 대한구강악안면외과학회지2009 · 제35권 제3호Clinical characteristics, pathological distribution, and prognostic factors in non-Hodgkin lymphoma of Waldeyer’s ring: nationwide Korean study김원식, 김진석, 김효정, 서철원, 신호진, 이성준, 이순일, 이원식, 최철원, The Consortium for Improving Survival of Lymphoma대한내과학회 · The Korean Journal of Internal Medicine2014 · 제29권 제3호원발 위장관 미만 대 B세포 림프종의 임상상과 International Prognostic Index의 적용김신, 강윤구, 고옥배, 구자은, 김은희, 류민희, 서철원, 이단비, 정용필, 허주령대한내과학회 · 대한내과학회지2007 · 제72권 제1호Prognostic Impact of Helicobacter pylori Infection and Eradication Therapy in Gastric Mucosa-associated Lymphoid Tissue Lymphoma박상혁, 박서진, 박찬정, 장성수, 지현숙, 허주령대한진단검사의학회 · Annals of Laboratory Medicine2010 · 제30권 제6호Prevalence and Implications of Bone Marrow Involvement in Patients with Gastric Mucosa-Associated Lymphoid Tissue LymphomaChan Gyoo Kim, Hyeon Seok Eom, Hyewon Lee, Il Ju Choi, Jong Yeul Lee, Myeong-Cherl Kook, Sanghyun Hwang, Sang Il Choi, Soo-Jeong Cho, Young-Il Kim거트앤리버 소화기연관학회협의회 · Gut and Liver2018 · 제12권 제3호

이 간행물의 다른 논문 (12건)

The Ballooning Time in Endoscopic Papillary Balloon Dilation for the Treatment of Bile Duct Stones김형길, 이정일, 이진우, 김영수, 방병욱, 권계숙, 이돈행, 신용운, 정석pp. 239-245Left Ventricular Dyssynchrony in Patients Showing Diastolic Dysfunction without Overt Symptoms of Heart Failure김기주, 박정길, 신승민, 정병철, 강현재, 장희상, 이봉렬, 김재훈, 배병석pp. 246-252Combination of Uric Acid and NT-ProBNP: A More Useful Prognostic Marker for Short-Term Clinical Outcomes in Patients with Acute Heart Failure손지현, 김윤년, 윤혁준, 허승호, 남창욱, 박형섭, 김권배, 신홍원, 박희준, 김형섭, 조윤경pp. 253-259Familial Clustering of Type 2 Diabetes in Korean Women with Gestational Diabetes Mellitus김주영, 김영설, 김성훈, 우정택, 이상열pp. 269-272The Effect of Early Insulin Therapy on Pancreatic β-Cell Function and Long-Term Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients전숙, 김영설, 김성운, 오승준, 김진우, 우정택pp. 273-281
원문 보기